Outcomes of Infants with Mild Hypoxic Ischemic Encephalopathy Who Did Not Receive Therapeutic Hypothermia
Biomedicine Hub · 10.10.2019 · 4 (3) · 1-9
DOI: 10.1159/000502936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedicine Hub, online erschienen am 10.10.2019. Verfasst von Jonathan Reiss und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, School of Medicine, University of California, San Diego, San Diego, California, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Accurately diagnosing and treating infants with mild forms of hypoxic ischemic encephalopathy (HIE) is important, as the majority of neonates with signs and symptoms of HIE after birth do not meet clinical criteria for moderate or severe disease. Emerging evidence, however, suggests that infants with mild HIE (mHIE) have an increased risk for neurodevelopmental impairment (NDI).
Methods
This retrospective descriptive study examined all inborn infants ≥35 week’s gestational age at a single, level III neonatal intensive care unit (NICU) in California between January 1, 2012, and December 31, 2015. International Classification of Diseases codes were used as a proxy to identify neonates with mHIE but who did not receive therapeutic hypothermia (TH). Short- and long-term neurodevelopmental outcomes were documented, including abnormal (1) brain magnetic resonance imaging within 10 days of birth suggestive of HIE, (2) electroencephalogram with electrographic seizures, (3) neurologic discharge examination, or (4) NDI following NICU discharge.
Results
Over the 4-year study period, 25 infants met inclusion criteria. Eight of 25 (32%) infants demonstrated neurologic impairment, defined by an abnormality in at least one of the four categories. The remaining 17 infants were without documented evidence for adverse outcomes.
Conclusion
Our results indicate that children with mHIE are at significant risk for neurologic injury and may benefit from more aggressive interventions. Further prospective studies should be completed to determine the efficacy of TH in this specific patient population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, School of Medicine, University of California, San Diego, San Diego, California, USA.
- Department of Bioengineering, University of California, San Diego, San Diego, California, USA.
- Division of Pediatric Neurology, Department of Pediatrics, School of Medicine, University of California, San Diego, San Diego, California, USA.
- Department of Radiology, School of Medicine, University of California, San Diego, San Diego, California, USA.
- Division of Neonatal-Perinatal Medicine, Department of Pediatrics, School of Medicine, University of California, San Diego, San Diego, California, USA.
Zitieren
APA
Reiss, J., Sinha, M., Gold, J., Bykowski, J., & Lawrence, S. M. (2019). Outcomes of Infants with Mild Hypoxic Ischemic Encephalopathy Who Did Not Receive Therapeutic Hypothermia. Biomedicine Hub, 4(3), 1-9. https://doi.org/10.1159/000502936
Vancouver
Reiss J, Sinha M, Gold J, Bykowski J, Lawrence SM. Outcomes of Infants with Mild Hypoxic Ischemic Encephalopathy Who Did Not Receive Therapeutic Hypothermia. Biomedicine Hub. 2019;4(3):1-9. doi:10.1159/000502936
BibTeX
@article{Reiss2019,
author = {Reiss, Jonathan and Sinha, Mridu and Gold, Jeffrey and Bykowski, Julie and Lawrence, Shelley M},
title = {Outcomes of Infants with Mild Hypoxic Ischemic Encephalopathy Who Did Not Receive Therapeutic Hypothermia},
journal = {Biomedicine Hub},
year = {2019},
volume = {4},
number = {3},
pages = {1--9},
doi = {10.1159/000502936}
}
EUVIMED